 |
|
Quote of the Month
"The MedaCube has been wonderful for our PACE participants. It has improved adherence, helped us keep participants out of nursing homes, and saved lives!"
- Rhonda Wright, RN, Center Manager
|
PACE Case: Hydrochlorothiazide and Lithium
A 64-year-old African-American male with a history of hypertension, coronary artery disease, and schizophrenia is newly enrolled in PACE.
The participant's medication regimen includes:
* Amlodipine, 5mg QD
* Acetylsalicylic acid, 81mg QD
* Fluphenazine decanoate 50mg, q2 weeks
* Lithium ER, 450mg BID
* Valsartan, 160mg QD (changed to Losartan, 100mg QD due to shortage)
* Zyprexa, 10mg QHS
|
CareKinesis Webinar Series - Diabetes Mellitus: Cost-Effectiveness of Treatment Therapies
Join us on Tuesday, December 11, 2018, at 12:00 p.m. and 3:00 p.m. EST for a webinar on Diabetes Mellitus: Cost-Effectiveness of Treatment Therapies, presented by Tyler Ballinghoff, PharmD, CareKinesis, and Briana Skalski, PharmD, CareKinesis.
The webinar objectives are to:
- Provide a brief overview of Diabetes Mellitus, including pathophysiology, epidemiology, risk factors, and diagnosis.
- Review guideline-based approaches to treating Type 2 Diabetes Mellitus (T2D).
- Discuss details of medication classes used to treat T2D, including average reduction in HbA1c, mechanism of action, adverse effects, contraindications, and their relative cost.
- Compare cost-effectiveness across medication classes used to treat T2D.
Register for one of the sessions now.
|
CareKinesis Launches Medication Risk Management and Pharmacy Services for Rocky Mountain PACE
CareKinesis is now providing its comprehensive PACE medication risk management services to Rocky Mountain PACE, a program of Rocky Mountain Health Care Services, based in Colorado Springs, CO.
Rocky Mountain PACE's services include physical, social, and emotional health care, as well as transportation and support services that help participants access care, all with the goal of keeping them independent and healthy as long as possible.
|
Orsula V. Knowlton, PharmD, MBA Featured in Recent Publications
Orsula V. Knowlton, PharmD, MBA, President, CareKinesis, was recently featured in the Thrive Global article, "Women of the C-Suite: Practice blameless problem solving With Dr. Orsula Knowlton," where she discusses having blameless conversations to get to the root-cause of problems and make collaborative improvements.
In addition, she and Calvin H. Knowlton, BScPharm, MDiv, PhD, CEO, Chairman and Founder of CareKinesis, were featured in the
Forbes article, "
Meet Tabula Rasa HealthCare, The Top Publicly-Traded Digital Health Company."
|
Tabula Rasa HealthCare, Inc. (TRHC) Acquires Cognify
TRHC recently completed the acquisition of healthcare technology company, Cognify. Cognify focuses on enabling patient-centered, multidisciplinary, coordinated, and integrated care along with financial management for PACE, as well as managed long-term care and medical home providers. Cognify's expertise enables clients to seamlessly integrate turnkey software solutions for optimal business performance and participant outcomes.
|
|
Food Safety Warning: Outbreak of E. coli Infections Linked to Romaine Lettuce
The Centers for Disease Control and Prevention (CDC), public health, and regulatory officials in the U.S. and Canada, as well as the U.S. Food and Drug Administration are investigating a multi-state outbreak of Shiga toxin-producing E. coli O157:H7 infections linked to romaine lettuce. As a result, the CDC is advising that U.S. consumers not eat, and retailers and restaurants not serve or sell, any romaine lettuce harvested from the Central Coastal growing regions of northern and central California.
|
|
Upcoming Events & Reminders
December
|
|
From the CareKinesis Family!
|
|
|
|
|
|
